Edgewise Therapeutics, Inc.EWTXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P43
Within normal range
vs 3Y Ago
-7.4x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -10.97% |
| Q3 2025 | -6.73% |
| Q2 2025 | 13.95% |
| Q1 2025 | -40.47% |
| Q4 2024 | 1.52% |
| Q3 2024 | -4.89% |
| Q2 2024 | 8.74% |
| Q1 2024 | -6.59% |
| Q4 2023 | -21.63% |
| Q3 2023 | -9.01% |
| Q2 2023 | 11.36% |
| Q1 2023 | -93.11% |
| Q4 2022 | 1.48% |
| Q3 2022 | 26.14% |
| Q2 2022 | -29.22% |
| Q1 2022 | -33.47% |
| Q4 2021 | -14.00% |
| Q3 2021 | 15.43% |
| Q2 2021 | -61.28% |
| Q1 2021 | -30.60% |
| Q4 2020 | -41.75% |
| Q3 2020 | 17.89% |
| Q2 2020 | -45.49% |
| Q1 2020 | 0.00% |